Puerarin Alleviates UUO-Induced Inflammation and Fibrosis by Regulating the NF-κB P65/STAT3 and TGFβ1/Smads Signaling Pathways
Jingyu Wang,Shuke Ge,Yaqing Wang,Yi Liu,Lihua Qiu,Junying Li,Xin Huang,Li Sun
DOI: https://doi.org/10.2147/DDDT.S321879
2021-08-24
Abstract:Jingyu Wang, 1 Shuke Ge, 2 Yaqing Wang, 1 Yi Liu, 3 Lihua Qiu, 4 Junying Li, 4 Xin Huang, 1 Li Sun 1 1 Department of Nephrology, The First Affiliated Hospital of China Medical University, Shenyang, 110000, Liaoning Province, People's Republic of China; 2 Department of Emergency management, Liaoning Center for Disease Control and Prevention, Shenyang, 110000, Liaoning Province, People's Republic of China; 3 Department of Anesthesiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, Sichuan Province, People's Republic of China; 4 Department of epigenetics, China Medical University, Shenyang, 110000, Liaoning Province, People's Republic of China Correspondence: Li Sun The First Affiliated Hospital of China Medical University, North Nanjing Street 155#, Heping District of Shenyang, Liaoning Province, 110000, People's Republic of China Tel +86 24-83282506 Email Purpose: Puerarin (PR), a Chinese medicine rich in natural components, has been reported to display anti-fibrotic, antioxidant, anti-inflammatory and immunomodulatory properties. However, the protective mechanism of PR against unilateral ureteral obstruction (UUO)-mediated renal injury is not fully clarified. Therefore, the aim of this study was to investigate the effects of PR on UUO mice and its possible mechanisms. Methods: A total of 32 C57BL/6 mice were divided randomly into four groups (n=8): i) sham-operated group (Sham); ii) UUO group (UUO); iii) UUO + PR 50 mg/kg/day (UUO + PRL); and iv) UUO + PR 100 mg/kg/day (UUO + PRH). Continuous gavage administration for 14 days starting one week postoperatively, while the mice in Sham and UUO groups were given equal amounts of vehicle by the same means. All mice were then sacrificed and serum, 24-hour urine and tissue specimens were collected for renal function, histopathology, Western blot, immunohistochemistry. Results: Renal function and histopathology revealed that PR improved UUO-mediated renal dysfunction and partially reversed tubular injury and tubulointerstitial fibrosis. Additionally, according to the results of Western blot and immunohistochemistry, PR inhibited the expression of inflammatory factors including IL-1β, IL-6, MCP-1 and ECM-related proteins including α-SMA, COL I and VIM. More importantly, the expression of fibrotic pathways TGF-β 1, Smad3, p-Smad3 and inflammatory pathways NF-κB p65, NF-κB p-p65, STAT3, p-STAT3 were inhibited to various extents under the PR treatment, while Smad7 was upregulated. Conclusion: These findings indicate that PR may inhibit the recruitment of inflammatory factors and extracellular matrix (ECM) deposition through the regulation of the NF-κB p65/STAT3 and TGFβ 1/Smads pathways, which alleviates the UUO-induced inflammatory and fibrotic response, thereby reversing renal injury. Keywords: puerarin, UUO, CKD, inflammation, fibrosis According to statistics, the global prevalence of chronic kidney disease (CKD) has reached 13.4% with increasing rates annually, 1 which has reduced the patient's life quality and posed an escalating challenge to public health. Renal fibrosis is a common pathological feature of CKD progression to end-stage renal disease (ESRD), distinguished by ECM sedimentation. 2 The ongoing cell death and inflammatory cell infiltration during the evolution of tissue fibrosis is often accompanied by the release of large amounts of cytokines, inflammatory chemokines and growth factors, which promote cell proliferation. 3 In addition, free radicals produced by inflammatory cells also contribute to the development of fibrosis by inducing epithelial-mesenchymal transition (EMT). 4 Inflammation and fibrosis are protective host cell responses to infection and injury, characterised by the recruitment of pro-inflammatory factors, pro-fibrotic factors and immune cells to the lesion, 5,6 resulting the inflammatory and fibrotic cascades to amplify and interplay with other signalling molecules, both of which promote and impact on each other. It is therefore critical to intermediate the progression of inflammation and fibrosis to facilitate the repair of tissue structure and function. As one of the critical subunits of the NF-κB family, p65 is mainly involved in systemic defence responses, such as inflammation, injury, apoptosis and tumour suppression. 7 High activation of p65 can be observed in inflammatory lesions, which is associated with NF-κB-induced expression of inflammatory cytokines, inflammatory enzymes and adhesion molecules, thereby accelerating the inflammatory response. 8–10 Regulation of p65 signalling molecules can rescue kidney injur -Abstract Truncated-